Formulation of amorphous ternary solid dispersions of dapagliflozin using PEG 6000 and Poloxamer 188: solid-state characterization, ex vivo study, and molecular simulation assessment-Reference-Cited by-同舟云学术

Formulation of amorphous ternary solid dispersions of dapagliflozin using PEG 6000 and Poloxamer 188: solid-state characterization, ex vivo study, and molecular simulation assessment

Published:2020-08-05 Issue:9 Volume:46 Page:1458-1467
ISSN:0363-9045
Container-title:Drug Development and Industrial Pharmacy
language:en
Short-container-title:Drug Development and Industrial Pharmacy

Author:

Alruwaili Nabil K.¹,Zafar Ameeduzzafar¹,Imam Syed Sarim²,Alharbi Khalid Saad³,Alshehri Sultan²⁴,Elsaman Tilal⁵⁶,Alomar Fadhel Ahmed⁷,Akhtar Sultan⁸,Fahmy Usama A.⁹,Alhakamy Nabil A.⁹,Alshammari Mohammed Salem¹⁰

Affiliation:

1. Department of Pharmaceutics, College of Pharmacy, Jouf University, Sakaka, Saudi Arabia

2. Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia

3. Department of Pharmacology, College of Pharmacy, Jouf University, Sakaka, Saudi Arabia

4. College of Pharmacy, Almaarefa University, Riyadh, Saudi Arabia

5. Department of Pharmaceutical Chemistry, College of Pharmacy, Jouf University, Sakaka, Saudi Arabia

6. Faculty of Pharmacy, Omdurman Islamic University, Omdurman, Sudan

7. Department of Pharmacology, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia

8. Department of Biophysics Research, Institute for Research and Medical Consultant, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia

9. Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia

10. Department of Pharmacy Practice, Unaizah College of Pharmacy, Qassim University, Buraydah, Saudi Arabia

Publisher

Informa UK Limited

Subject

Organic Chemistry,Drug Discovery,Pharmaceutical Science,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/03639045.2020.1802482

Reference47 articles.

1. Preparation and characterization of rilpivirine solid dispersions with the application of enhanced solubility and dissolution rate

2. Dissolution Enhancement and Characterization of Nimodipine Solid Dispersions with Poloxamer 407 or PEG 6000

3. Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine (II): In vivo evaluation

4. Development of novel dapagliflozin loaded solid self-nanoemulsifying oral delivery system: Physiochemical characterization and in vivo antidiabetic activity

5. Dapagliflozin, a Novel SGLT2 Inhibitor, Induces Dose-Dependent Glucosuria in Healthy Subjects

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential of sonocrystallization in crystal habit modification for improving micromeritic and physicochemical properties of Dapagliflozin;Chemical Engineering Research and Design;2024-07

2. In Vitro and Biological Evaluation of Oral Fast-Disintegrating Films Containing Ranitidine HCl and Syloid® 244FP-Based Ternary Solid Dispersion of Flurbiprofen;Pharmaceutics;2024-01-24

3. Computer numerical control (CNC) carving as an on-demand point-of-care manufacturing of solid dosage form: A digital alternative method for 3D printing;International Journal of Pharmaceutics;2023-10

4. Fabrication, optimization, and eco-friendly micellar HPLC determination of Alogliptin/Dapagliflozin pullulan-based sublingual films for therapeutic efficacy improvement in diabetic rats;Journal of Drug Delivery Science and Technology;2023-04

5. An ultrasonographic assisted investigation for the enhancement of duodenal/cecal motility of mosapride through a surfactant-based triple solid dispersion: In-vitro, in-vivo assessment of tablet formulation;Journal of Drug Delivery Science and Technology;2021-10